Engineered Microorganisms for Mid-Chain Oleochemical Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current biological gas-to-liquid (GTL) technologies face challenges in producing mid- to long-chain lipid-based chemicals and oleochemicals efficiently, as they are limited by short carbon chain production, sensitivity to impurities, and low tolerance for syngas constituents, leading to high costs and environmental impacts.
Innovation Solution
Engineered microorganisms, such as Rhodococcus opacus and Cupriavidus necator, are developed to convert CO2 and syngas into higher value mid- to long-chain oleochemicals and monomers, utilizing genetic modifications to enhance lipid biosynthesis pathways and tolerate varying syngas ratios, thereby producing targeted products with increased efficiency and flexibility.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If current biological GTL technologies are used to produce lipid-based chemicals, then carbon fixation occurs, but the production is limited to short carbon chain lengths
Solution Approach 1:
The patent modifies the biochemical parameters of microorganisms by introducing heterologous genes (e.g., fas gene from Arabidopsis thaliana) to alter fatty acid biosynthesis pathways. This enables the production of mid- to long-chain fatty acids (C10-C20) instead of being limited to short-chain products, directly addressing the carbon chain length limitation while maintaining biological productivity
2Reliability
If conventional biological GTL processes are employed, then carbon conversion occurs, but sensitivity to impurities and low tolerance for syngas constituents result in high costs
Solution Approach 1:
The patent genetically engineers microorganisms to change their physiological parameters, specifically enhancing their tolerance to syngas constituents like CO2, CO, and H2. The modified strains can withstand varying gas compositions and impurities without requiring costly purification steps, thereby reducing operational costs while maintaining reliable carbon conversion
3Productivity
If traditional algal systems are used for hydrocarbon production, then photosynthetic carbon fixation occurs, but insufficient yields limit economic feasibility
Solution Approach 1:
The patent replaces photosynthetic carbon fixation (used in algal systems) with chemosynthetic carbon fixation using engineered bacteria. This substitution enables higher productivity by utilizing heterologous fatty acid biosynthesis pathways that can achieve yields of 50-80% of total cellular mass as lipids, making the process economically feasible compared to traditional algal systems
4Productivity
If heterotrophic fermentation systems are employed, then sugar feedstock conversion occurs, but food versus fuel conflict and environmental impacts arise
Solution Approach 1:
The patent enables microorganisms to use gaseous carbon sources (CO2, CO, H2) directly for carbon fixation and lipid synthesis, making the system self-sufficient without requiring sugar feedstocks. This eliminates the food versus fuel conflict and reduces environmental impacts associated with agricultural feedstock production, while maintaining high productivity in organic compound production
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered microorganisms enable the cost-effective synthesis of long-chain oleochemicals and fuels, competing with petrochemical prices, while reducing environmental impacts and operational costs, and producing a narrower range of carbon chain lengths with improved product recovery.
Implementation Method 1
the bacteria of the invention can be genetically engineered for use in the methods or other aspects of the invention described herein... methods of fixing carbon from gas input into useful organic molecules
Implementation Method 2
utilizing genetic modifications to enhance lipid biosynthesis pathways and tolerate varying syngas ratios, thereby producing targeted products with increased efficiency and flexibility
Implementation Method 3
Engineered microorganisms, such as Rhodococcus opacus and Cupriavidus necator, are developed to convert CO2 and syngas into higher value mid- to long-chain oleochemicals and monomers, utilizing genetic modifications to enhance lipid biosynthesis pathways and tolerate varying syngas ratios
Data Source
AI summary
Compositions and methods for a hybrid biological and chemical process utilizing chemotrophic microorganisms that converts syngas and/or gaseous CO2 and/or a mixture of CO2 gas and H2 gas into one or more desaturated hydrocarbons, unsaturated fatty acids, hydroxy acids, or diacids.


